久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語(yǔ)Fran?ais
Latest News

Pharmaceutical enterprises making innovation faster and more relevant

By He Wei in Shanghai | China Daily | Updated: 2020-07-23 11:43
Share
Share - WeChat
Visitors at the exhibition area of French pharmaceutical giant Sanofi during the second China International Import Expo in Shanghai on Nov 10, 2019. [Photo/Xinhua]

Global pharmaceutical enterprises are looking to boost business operations in China in a bid to make innovation faster and more relevant to the market.

Business executives attribute the upbeat prospects in China to a thriving digital landscape, strong on-the-ground demand for innovation as well as government efforts to cut red tape and encourage technological breakthroughs.

In July, German science and technology conglomerate Merck opened its M Lab Collaboration Center in Shanghai-an in-house facility that fosters new drug development and offers customized solutions from services to training.

Albeit being the ninth such hub worldwide, the one-stop, technology and training center houses 13 labs and claims to be the biggest of its kind for Merck. It boasts four new functionalities including supporting food and beverage security-related inspections as well as environmental industries that are exclusive to the China market.

"The M Lab means faster turnaround, lowered costs as no travel out of China is needed, access to a vast network of biologics and bio-development experts within Merck and enhanced customer convenience," said Steve Vermant, managing director of Merck Life Science China.

For instance, in a dedicated research lab into proteins-the fundamental building block of life sciences-the company provides solutions from protein preparation and analysis to a number of relevant research tools. These stand to provide customers in China with hands-on training and support them on method optimization and application extension.

The existing global network of M Labs has reaped gains across the value chain during the ongoing COVID-19 pandemic, said Ian Carmichael, vice-president and head of bio processing at Merck Life Science China.

"Some of the candidates for drugs or vaccines have been able to accelerate to commercialization because of the work that was done between Merck and the customers in the past. We can go from labs to clinical trials," Carmichael said.

1 2 Next   >>|

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 日韩中文字幕精品一区在线 | 欧美成人免费sss | 国内精品免费一区二区观看 | 亚洲国产精品欧美日韩一区二区 | 国产高清一区二区 | 美女又黄又免费 | 亚洲精品m在线观看 | 成年女人免费视频播放成年m | 精品极品三级久久久久 | 中国国语毛片免费观看视频 | 亚洲高清免费观看 | 亚洲毛片免费在线观看 | 国内精品线在线观看 | 草草视频在线播放 | 国产一国产a一级毛片 | 亚洲制服丝袜美腿亚洲一区 | 天天爱天天做天天爽天天躁 | 午夜欧美精品久久久久久久久 | 99精品视频观看 | 亚洲男人的天堂久久精品 | 爱爱客影院在线影院gf发现 | a毛片基地免费全部香蕉 | 毛片免费高清免费 | 成年人在线免费网站 | 97久久草草超级碰碰碰 | 国产成人精品日本亚洲语音1 | 久久久久久久久久久9精品视频 | 在线观看日本免费视频大片一区 | 日韩精品午夜视频一区二区三区 | 国产三级日产三级韩国三级 | 国产午夜精品理论片免费观看 | 免费高清国产 | 女人野外小树林一级毛片 | a级毛片免费在线观看 | 亚洲理论片在线中文字幕 | 欧美一级大片免费看 | 91情侣在线偷精品国产 | 亚洲在线天堂 | 国产精品久久久久久久久免费hd | 国产成人免费观看在线视频 | 欧美在线bdsm调教一区 |